The downstream effects of CJC-1295 and ipamorelin on growth hormone secretion converge on the insulin like growth factor 1 axis, which integrates the pituitary growth hormone signal into the broader systemic endocrinology of growth, metabolism, and tissue repair. Research on the IGF-1 axis is therefore a natural extension of the CJC-1295 and ipamorelin literature, and it provides the biological link between the receptor level pharmacology discussed in the CJC-1295 / Ipamorelin Blend: What Researchers Need to Know and the systemic research endpoints that define downstream bioactivity.
CJC/Ipa IGF-1 Axis Research: Downstream Growth Hormone Signaling Studies
CJC-1295 / Ipamorelin · Published April 14, 2026 · Updated May 18, 2026 · 9 min read
Quick Answer
CJC-1295/Ipamorelin IGF-1 axis research examines downstream growth hormone signaling, hepatic IGF-1 synthesis, and IGFBP binding protein dynamics in rodent models. Studies measure circulating IGF-1, IGFBP-3, and ALS levels alongside tissue-level IGF-1 receptor responses. For research use only, not for human consumption.
Research Use Only. All products are strictly for research use only (RUO). Not for human consumption. Products on this site are not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the FDA. By purchasing, you agree that you are a qualified researcher and that products will be used solely for in-vitro research purposes.
- The Growth Hormone IGF-1 Axis in Research Context
- IGF-1 Binding Proteins and Bioavailability
- Temporal Dynamics of IGF-1 Response
- Pulsatile versus Sustained IGF-1 Response
- Local IGF-1 in Tissue Research
- Research Design Considerations for IGF-1 Endpoints
- Research Peptides Referenced
- Related Research Reading
- Related Research Articles
- Explore Related Products
- Frequently Asked Questions
- Glossary
Frequently Asked Questions
What is CJC-1295 in research contexts?
+
CJC-1295 is a synthetic 30-amino-acid analog of growth hormone-releasing hormone (GHRH). It is studied in research models as a long-acting GHRH receptor agonist that drives pulsatile growth hormone release from the pituitary.
How does the CJC/Ipa combination affect IGF-1?
+
The combination drives larger and more frequent GH pulses, which in turn elevate hepatic IGF-1 synthesis through GH receptor JAK2/STAT5 signaling. Plasma IGF-1 and IGFBP-3 are reliable downstream biomarkers of integrated GH exposure in research.
What IGF-1 binding proteins are studied in CJC/Ipa research?
+
IGFBP-3 is the dominant circulating IGF-1 binding protein and is GH-regulated, making it a complementary biomarker. ALS (acid-labile subunit) is also measured. Together with IGF-1, these proteins form the ternary complex that determines IGF-1 bioavailability.
Is CJC-1295 approved for human use?
+
No. CJC-1295 is not approved by the FDA for any human therapeutic use. It is supplied strictly for in-vitro and preclinical research purposes by qualified investigators.
Glossary
Key terms used in this article.
- GHRH
- Growth hormone-releasing hormone, the hypothalamic peptide that stimulates pituitary growth hormone release.
- DAC (Drug Affinity Complex)
- A maleimidopropionic acid linker on CJC-1295 that covalently binds serum albumin to extend half-life.
- Pulsatile Release
- The episodic, rhythmic secretion pattern characteristic of growth hormone from the anterior pituitary.
- Pituitary Somatotroph
- The anterior pituitary cell type that synthesizes and secretes growth hormone.
- IGF-1
- Insulin-like growth factor 1, the primary downstream mediator of growth hormone action, produced largely in the liver.
- GHS-R1a
- Growth hormone secretagogue receptor 1a, the ghrelin receptor through which ipamorelin signals.
- GHRP
- Growth hormone-releasing peptide, a class of synthetic ghrelin receptor agonists that stimulate GH release.
- Ghrelin
- The endogenous 28-amino-acid acylated peptide hormone that activates GHS-R1a and stimulates appetite and GH release.
More from the Blog
Continue exploring research insights and updates.
Research Use Only. All products are strictly for research use only (RUO). Not for human consumption. Products on this site are not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the FDA. By purchasing, you agree that you are a qualified researcher and that products will be used solely for in-vitro research purposes.
